Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$12.7 - $17.92 $163,830 - $231,168
-12,900 Reduced 22.43%
44,600 $566,000
Q2 2024

Aug 15, 2024

BUY
$12.72 - $19.2 $389,232 - $587,520
30,600 Added 113.75%
57,500 $964,000
Q1 2024

May 07, 2024

BUY
$13.81 - $19.33 $371,489 - $519,976
26,900 New
26,900 $403,000
Q3 2023

Nov 14, 2023

BUY
$8.84 - $22.64 $45,968 - $117,728
5,200 Added 39.1%
18,500 $259,000
Q2 2023

Aug 11, 2023

BUY
$8.75 - $14.29 $116,375 - $190,057
13,300 New
13,300 $137,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $242M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.